We aim to foster a culture of entrepreneurship, innovation and success among engineers in the UK, creating economic growth and societal impact. At the heart of how we do this are the Hub Members, the promising entrepreneurs who we support through our programmes, and our Hub Mentors, the business leaders who volunteer their expertise and time to help the Hub Members succeed.
From manufacturing to medtech, our Hub Membership is made up of some of the UK’s most innovative entrepreneurs. But don’t just take our word for it: read more about our Hub Members to see how they are, without exaggeration, changing the world.
Product development is a complex phase in the product life cycle, which spans from idea to pre-manufacturing. It is characterised by challenges such as ambiguity, uncertainty and continuous change as the product evolves from a concept to a fully manufacturable product.
A single development project often costs billions of pounds, requires multiple years and involves tens of thousands of employees and hundreds of thousands of activities.
Due to their scale and sophistication, 45% of these projects miss their time target, 63% miss their cost targets, and for every $1 billion spent about $120 million is lost due to inefficiencies.
AEMS has used cutting-edge research in artificial intelligence and project management to create a software solution that enables firms to plan and manage their projects more efficiently. The AI-powered solution enables companies to predict the performance of their projects, identify optimal execution plans and helps them to make more informed and tested decisions.
Over the next 12 to 18 months, AEMS intends to build its product from a basic prototype to a full commercial version, adding extra functionalities in the process. Alongside this, AEMS will execute a series of customer testing activities. The online project management software market is currently valued at £3 billion [PS1] and expected to double over the next five years. These tests will evaluate the value that its product adds to the customer, the user-friendliness of the software, and whether customers are willing to purchase it.
2014 - 2017: Developed the technology at the University of Cambridge.
2018 - 2019: Carried out a proof-of-principle study at Jaguar Land Rover.
2020 - Awarded a Royal Academy of Engineering Enterprise Fellowship.
2020 - Received pre-seed investment from Cambridge Enterprise.
2020 - Implemented additional features.
2020 - Set up second industrial collaboration for further customer testing.
“The Enterprise Fellowship programme has been enormously supportive through providing funding and, more importantly, a comprehensive training programme delivered by world-class experts covering the various aspects of entrepreneurship.”
An increasing number of organisations and businesses have declared ambitious plans to become carbon neutral, but lack the ability to develop a tangible action plan. This is due to lack of information, and not having an easy way to evaluate various emission-reduction measures efficiently and at scale.
Absolar develops computer technologies that use remote sensing and artificial intelligence to capture building characteristics and evaluate their potential to improve energy efficiency and use renewable energy systems.
Its software, Carbon Action Planning Tool (CAPT), is a business-facing application that helps organisations assess individual buildings and identify measures that can be undertaken to reduce greenhouse gas emissions. The software helps users review the feasibility and cost-effectiveness of each project, supporting their decision-making process, and developing long-term action plans.
Absolar’s web-based application, Intelligent Energy Resource Assessment (INTERA), provides users with accurate and independent assessment results of the feasibility of installing solar energy panels on their buildings. It is integrated with latest market information and financial modelling and helps organisations, businesses and households install renewable energy systems to reduce energy costs, decrease their carbon footprint and gain carbon credits.
As of October 2020, over 300 local authorities in the UK have declared a climate emergency. The UK government’s intention to reach net zero is costed at £1 trillion by 2050 (BEIS, 2019) and requires 54 GW of solar capacity to be installed by 2035, equivalent to around £2.2 billion of investment per year. With this in mind, Absolar aims to achieve nationwide coverage and bring its software to all cities in the UK, and reach the overseas market by 2022. Absolar is also hoping to work with partners from the energy industry and local authorities to extend the application of its technologies.
Absolar’s software has been purchased by Portsmouth and Southampton city councils. It has received a European Regional Development Fund R&D grant, through the EMphasis3 CO2 Reduction Project run by the University of Portsmouth, University of Winchester and Greentech South.
January 2020 – Awarded a Royal Academy of Engineering Enterprise Fellowship.
June 2020 – Received revenue from software application and established a customer-funded business model.
November 2020 – launch of software application for southeast England (planning).
“With the valuable support from the Enterprise Fellowship, Absolar has been able to comprehensively examine a series of potential business models and identify the most suitable business structure and route to market.”
There is currently a dire need in the UK construction industry for insulation materials that are affordable, high-performance and fire-safe. This was highlighted by the 2017 Grenfell tower tragedy, which led to the ban of the most common plastic-based insulation materials in buildings above five storeys. All existing fire-safe alternatives are either expensive or low-performing, and with more than 30% of the UK’s carbon emissions resulting from gas-heating homes and offices, there has never been a greater need for novel solutions in this £850 million-a-year market.
Thermulon has developed a novel chemical process to produce silica aerogel powders. Silica aerogels are inherently non-flammable and one of the most insulating materials, but have historically been kept out of the construction industry due to high cost. This cost is largely due to their processing method, and Thermulon’s unique pathway significantly reduces price when produced at scale. Its vision is to use this to make buildings safer and more energy efficient.
Thermulon’s technology presents vast potential benefits commercially, environmentally and socially. Uninsulated UK solid wall homes alone lose 1.6 Terawatt-hours of energy per year (equivalent to the annual usage of 440,000 households). By addressing this market with its retrofit-applicable products, Thermulon can help the UK reach its 2050 carbon neutral goals. Fuel poverty remains an issue in 10% of UK households, and Thermulon’s solution can improve heating efficiency while consuming minimal floorspace, presenting an ideal solution for ECO3 government-funded projects in low-income and vulnerable households.
In the next 18 months, Thermulon aims to scale its material production capacity to be able to produce its first integrated insulation products and carry out demonstration projects in homes and buildings. Having the first demonstration home insulated with Thermulon material will be a major milestone that proves both the viability of the production process and its applicability to commercial use cases. The company will need to scale the process, work with development partners in final products such as plasters and renders, and collaborate with architectural firms to achieve this.
Thermulon has taken equity investment from both Deep Science Ventures and Sustainable Ventures. In addition to the Royal Academy of Engineering’s Enterprise Fellowship, it has been awarded the Royal Society of Chemistry’s Emerging Tech Prize. Thermulon is collaborating with several development and commercial partners including the Centre for Process Innovation, Imperial College London, and lime render and plaster manufacturer Best of Lime.
August 2019 - Pre-seed equity investment from Deep Science Ventures.
October 2019 - First proofs of chemistry with Durham University and the Centre for Process Innovation.
April 2020 - Seed round equity investment from a consortium including Sustainable Ventures and climate-focused angel investors.
August 2020 - Awarded SMART Grant with Best of Lime and Imperial College London .
November 2020 - SMART Grant Kickoff for aerogel and plaster development and scaling.
“The Enterprise Fellowship has been key in helping Thermulon to focus its technical development on commercial goals and understand the landscape of the UK startup funding industry. Personally, the Fellowship has also proved vital to me as an awardee in providing guidance in the transition from employee to entrepreneur, and in connecting me with a group of like-minded individuals embarking on the same journey.”
Losing your eyesight is one of the most devastating things that can happen to a person.
Some forms of vision loss that affect the retina, such as age-related macular degeneration (AMD), or diabetes can be treated. This requires monthly injections into the eye for at least five years. The treatment works well for most people but requires regular outpatient visits and there is a small risk of additional complications from the injection process itself.
There is a real need to make treatments better, safer and more convenient.
I-Daruma has developed a technology that takes the same treatment and makes it possible to deliver the currently injected drugs as eye drops instead. It works by creating short-lived nanoparticles that are mixed with the drugs. These then dissociate at the target tissues, releasing the drug. The nanoparticles are made from compounds that naturally occur in the body and are well-tolerated, giving the technology the advantages of nanoparticle delivery without the toxicity associated with current nanoparticles.
The eye drops will address several issues with the current treatment regime. While injections must be administered by trained healthcare professionals in a clinical setting, eye drops can be administered by the patient themselves anywhere, resulting in large healthcare cost savings.
Worldwide, there were 14 million intravitreal injections performed in 2018 and it’s a number that has been growing 20% year-on-year. The drivers of treatment are the ageing global population and metabolic disease such as diabetes. About one third of people living with diabetes will suffer from diabetic retinopathy. Age-related macular degeneration (AMD) is also a leading cause of vision loss in Europe and the US. Currently, 196 million people are estimated to be affected by AMD globally, a figure expected to hit 288 million by 2040.
In the next 12 to 18 months, Naa Dei anticipates applying for InnovateUK Grant funding and looks forward to completing pre-clinical trials and having a dossier for approval for clinical trials.
2020 – Awarded a Royal Academy of Engineering’s Enterprise Fellowship.
2020 – Piloting trials of technology with a pharmaceutical company.
“[The Enterprise Fellowship] has opened my eyes to what goes into turning a neat idea into a business and has equipped me with tools to do so. It’s an amazing network of people at different stages of their enterprises, and I’ve found it very supportive.”
Over two billion people worldwide lack access to safe drinking water. Membrane processes have been identified as effective techniques to remove contamination and salts from water. However, existing solutions are energy and capital intensive, require frequent maintenance and impose significant barriers to deployment.
Waterwhelm are commercialising a patent-pending process for wastewater treatment, water treatment, desalination and dewatering that will overcome these challenges by engineering the natural process of osmosis. The innovation has the potential to cut electricity consumption by a staggering 90% compared to current practice and reduce capital costs by more than 35%.
Over the next 12 months it will be developing, commissioning and testing a sizeable pilot plant that will validate the technology in an industrial environment. Waterwhelm aim to learn from the unit and receive feedback from early adopters based on its trial performance.
Supported by the University of Edinburgh, the Royal Academy of Engineering Enterprise Hub , Scottish Enterprise, Innovate UK and EIT Climate KIC, Waterwhelm has gained significant technical and commercial traction by developing one of the most promising technologies addressing problems faced by the rapidly growing global water market.
2018: Waterwhelm founded
2019: Winner of the Converge KickStart Challenge
2019: Awarded as the top enterprise emerging from the University of Edinburgh
2019: Pre-seed funding round completed
2020: Innovate UK Global Challenges Research Fund project starts
2020: First plant developed for technology validation in collaboration with a major industrial partner
“The Academy Enterprise Fellowship has provided the Waterwhelm founder with hands-on support in commercialising the technology.”
The fashion industry has a waste problem. Out of all clothing produced, 30% of it is never sold or worn.
Supply chain inefficiencies cost fashion companies an estimated $300 billion a year globally. Julija Bainiaksinaite founded MyFactori in 2014 to tackle this waste problem and is now building a platform for SME fashion brands to run and better optimise their supply chain logistics. Through raw material sourcing to production management and better demand forecasting, MyFactori is building a platform for companies to streamline their operations to reduce waste.
It is currently working towards securing founding partners and clients, and will launch its beta testing platform at the end of this year.
“The Enterprise Fellowship helped me to support my technology development and provided great educational resources on setting up a startup company.”
Text on many digital displays is designed to resemble a page in a book. This does not harness the dynamic, interactive, customisable potential of electronic screens. The current format is not designed with user experience in mind, but to be economical on space. For the visually impaired, the ‘steady-eye strategy’ is recommended, but no tool exists to achieve this. Lawyers and other professions have low productivity in reading-based tasks. The paragraph format does not fit well on small screens.
Predictive text allows machines to take on some of the burden of writing, by using predictable patterns in writing. BrightPage Tech is offering predictive text for reading. Like writing, there are patterns in the process of reading that can be predicted, allowing the machine to lighten the reader’s load.
When reading a line of text, our eyes do not move in a smooth, continuous movement; rather they move in a series of short, rapid jumps (saccades) and fixations. BrightPage’s core innovation is to make the text on the screen mimic these movements. Using a bank of eye tracking data, eye movements have been reverse engineered into an algorithm that takes any English text and presents it dynamically to optimise it for reading. The reader can relax and allow the electronic display device to do the hard work.
The first product in development aims to help some of the 285 million blind and partially sighted people worldwide. It enables them to use the ‘steady-eye strategy’, recommended when reading eccentrically. It is the only tool that targets this. Further products will target reading from small displays, speeding up reading-based tasks and immersive eBooks, with the company aiming to take advantage of the LegalTech AI market, which is growing at 36% annually.
BrightPage is currently validating the product market fit and making use of its partnerships with the Royal Academy of Engineering and Innovate UK.
2019: Selected for company formation from ICURe options roundabout
2020: Won £210,000 Innovate UK grant
2020: Won Scottish EDGE Wildcard competition
“[The Enterprise Fellowship] has provided training tailored to academics entering entrepreneurship, networking opportunities to raise investment and the funding to progress.”
Demand for e-Bikes across Europe is growing by 30% per year as people find them a fast and fun way to get around congested cities. However, most e-Bikes are too heavy and bulky to be used flexibly, for example with public transport.
FLIT develops lightweight folding e-bikes for urban commuters.
Folding e-bikes open up the market to new customers as they can be easily stored or used with public transport. By developing a folding e-bike from scratch, and integrating the electrical system into the frame, FLIT’s first product, the FLIT-16, is 30% lighter and smaller than a typical folding e-bike.
The first batch of FLIT-16s will be delivered to customers in late 2020. FLIT then plans to use feedback to continue experimenting in the folding e-bike niche. It will develop both new e-Bike models, for example to target customers in the leisure market, and new sales channels, such as leasing and subscription.
By the end of 2021, FLIT aims to have FLIT-16s available for purchase in shops across the UK, announce a new model of folding e-bike, and begin trialling a leasing scheme. In 2022 it hopes to expand into international markets in Europe and North America.
In 2019, 3.4 million e-bikes, worth £5 billion, were sold across the EU and UK. That volume had grown by an average of 31% a year since 2006. Folding bike sales also grew at about 15% a year over a similar period. The UK market for e-bikes is less mature than regional leaders such as the Netherlands or Germany, but is growing even faster. In the UK in 2018-19, the e-bike market grew by 66%, and folding e-bikes grew by over 200%.
2017 – Awarded Department for Transport Innovation Challenge Fund grant
2018 – Accepted onto the Design Council Spark accelerator, winning additional funding through a commendation award
2018 – Raised pre-seed investment from UK angels
2018 – Established a prototyping and manufacturing relationship in Taiwan
2019 – Filed a patent and registered designs for the FLIT-16
2019 – Eurobike Startup Award finalist and won ACID Design and IP Champion Award 2019 – Sold over 100 e-bikes via a Kickstarter pre-sales campaign, exceeding its target by 440%
2020 – Continued sales of the FLIT-16, and first deliveries to customers
“The business training has been extremely useful for expanding my knowledge of how the world of business really works, in particular my presentation, leadership and financial skills. The network obtained via the Academy is also very useful for raising investment rounds and consulting leading experts for advice.”
Electroplated coatings can become tarnished if exposed to corrosive environments.
Alex Nielsen has developed an electroplating additive that adds value to the metal coating by enhancing resistance to corrosion and tarnish.
Copper is naturally anti-microbial and anti-viral, but uncoated it readily corrodes, creating a maintenance problem for the end user. Armadillo Metal Coatings is currently testing the technical and commercial feasibility of its anti-tarnishing technology with copper electroplated coatings for door furnishings with a pair of world-leading industrial partners.
The door furnishing market is forecast to generate around £500 million in revenues in 2020, with demand for copper and brasses growing. This trend should accelerate due to COVID-19, as surfaces that can prevent the transmission of viruses and microbes become more sought after in hospitals, public areas and offices.
May 2020 - Closed first round of VC funding
August 2020 - Received £2,000 from Swansea University for project work to combat COVID-19.
“The Royal Academy of Engineering’s Enterprise Fellowship programme have provided very good advice on Venture Capital, grant funding and recruitment. The courses have been very useful, specifically sales and marketing. The award has also allowed our company to use university facilities during lockdown meaning technical development has progressed.”
What makes us different is the Academy’s Fellows and our wider Mentor network – an unrivalled community of the UK’s most successful industry leaders, technology experts and entrepreneurs. Find out more about our Mentors and their areas of expertise.
Dr Supti Sarkar leads the Technology and Investments Group at PwC. She is responsible for the commercialisation of new tech ventures across the firm, and works with in-house entrepreneurs to get their products market ready.
Supti was formally a management consultant at PA Consulting, where she worked with international and regional governments to support their trade and investment strategies. She was also part of Mayor Sadiq Khan's 2016 delegation to Chicago and New York as part of her role in supporting high growth companies entering the US market for the first time. Supti holds a first class degree and PhD in engineering from University College London and is mum to an eight-year-old daughter.
Dr Douglas C Anderson OBE FREng FRSE has a 40-year business career covering almost every aspect, at every level, of healthcare technology product design and product commercialisation processes.
Having trained in industrial design engineering (Edinburgh Napier University 1974), Douglas progressed from hands on designer to the management of design in the high-tech arena.
Using his consulting company Crombie Anderson as a base for innovation and incubation, he subsequently spun out three other high-tech startup companies, two of which became publicly traded business operating in medical fields.
Douglas was the prime mover in these businesses by leading both the innovation and commercialisation processes, including raising over £40 million in private and institutional funding prior to floatation. Today he is internationally recognised for his innovation and entrepreneurial experience and is a regular keynote speaker at healthcare and business congresses around the world.
In 1990, his five-year-old son Leif suffered a spontaneous retinal detachment that went undetected until it was too late to treat. Douglas was struck by the limited capability of diagnostic tools available to practitioners to examine the retina and decided to address this issue. He built a dedicated research team, which led to the formation of Optos plc, a business funded by Archangel from the outset.
Optos succeeded in designing and patenting a scanning laser ophthalmoscope: the world's first ophthalmic device that enabled eye care professionals to capture a digital ultra wide-field image of the almost the entire retina in a single scan. The new method of examining the retina, marketed as the optomap® Retinal Exam, is now offered as the preferred standard of care by tens of thousands of eye-care specialists globally. Over 200 million optomap® retinal exams have been conducted worldwide and a number of novel diagnostic techniques added to improve the understanding and treatment of a wider range of conditions that have been historically difficult to manage.
In 2006 Douglas was awarded an OBE for services to healthcare. Douglas was elected a Fellow of the Royal Academy of Engineering in 2013.
David is an investor and CEO with companies based on technology and innovation.
After a degree in electrical engineering at the Technion and an MBA from INSEAD, David worked his way to senior management and board level in a wide range of sectors including sustainability, construction, life sciences, manufacturing, mobile telephony, cyber security and software. His broad experience ranges from startups to public companies, from turnaround missions and crisis management to business development and growth.
David is deeply involved in the UK startup space, as a member of UKBAA, VCs, EIS funds and university angel groups, and is an active mentor with the Royal Academy of Engineering and Imperial College London’s IVMS programme. He also serves as a non-executive on the board of directors of Kerur Holdings (a public company), the board of governors of the Technion, as an advisor with the US accelerator Silicon Catalyst and the board of trustees of Hadassah UK.
He believes that success comes from a culture of excellence, a multidisciplinary approach, and that the boundaries between B2B/B2C and startups/LargeCo are increasingly blurred.
"Startups challenge and can defeat established companies. An explosion of new technologies will accelerate this trend. Large companies cannot afford to be on the defensive, they must proactively adopt a startup culture. But startups must also learn to be humble and pragmatic, build structures, communicate at a senior level, and strive to serve all their stakeholders, clients, staff, investors, and society as a whole. A fusion of cultures is now pivotal to success."
Richard joined sustainability investment focused Earth Capital Group in 2009 and has worked both on the group’s investment in investment managers and direct growth company investments, including most recently the fund’s investments in SoftIron and Propelair. He takes a leading role in promoting technology transfer opportunities across the group’s international offices.
Prior to joining Earth Capital, Richard was an Investment Director with IBIS Asset Management Ltd, a London-based captive advisor to a large Caribbean conglomerate. Richard was earlier a senior manager in the London office of L.E.K. Consulting, a global strategy consultancy. During his five years with LEK he provided due diligence advice, in numerous large cap and mid-market private equity deals, and advised corporate clients on corporate strategy, business unit growth strategy, process redesign and cost reduction programmes.
A chartered engineer, his early career included successful engineering, operations and customer support management roles with Ford Motor Company and Visteon Corporation. Richard holds an MBA with Distinction from INSEAD and MEng and MA (First Class) degrees in engineering from the University of Cambridge. He is a chartered member of the Chartered Institute of Securities and Investment, and a Chartered Member of the Institute of Engineering and Technology and a Sainsbury Management Fellow.
Dr Andrew Hosty FREng is an international leader with over 15 years of non-executive board experience and 30 years of executive and management experience, spanning private equity, UK Plc and global blue-chip corporates. He is non-executive director of a companies including: RHI-Magnesita, the global leader in the manufacture and supply of refractories; James Cropper Plc, who create some of the world’s most distinctive and technically advanced paper products; and Rights and Issues Investment Trust Plc, a fund that focuses on small cap UK industrials.
Andrew is Non-Executive Chairman of mOm Incubators ltd, a pre-revenue startup developing low-cost baby incubators for crisis zones. He is also Non-Executive Chairman of Nexeon ltd, a company developing next-generation cathode materials for lithium-ion batteries. From 2016 to 2018 Andrew was the CEO of the Sir Henry Royce Institute, the UK's home of advanced materials research and innovation. He was Chief Operating Officer of Morgan Advanced Materials, and served on the Plc Board as an Executive Director from 2010 to 2016.
From 2013 to 2016 he served on the board
of Consort Medical Plc, a healthcare company focused on developing advanced
delivery technologies, formulation and manufacturing solutions for drugs. He is
a Fellow of the Institute of Materials, holds a PhD from the Faculty of
Engineering at the University of Sheffield and is a Fellow of the Royal Academy
of Engineering (2011).
Chris McIntosh joined Methera Global as CEO in 2017. The company’s vision is to enable the delivery of digital applications to rural and underserved communities worldwide via a resilient constellation of Ka band MEO satellites. He previously spent seven years as CEO of ViaSat UK where he was responsible for the inception and growth of ViaSat’s UK satellite capabilities. Headquartered in the US, ViaSat are renowned as being one of the most disruptive players in the satellite communications and security domain.
Before joining ViaSat Chris was CEO of Stonewood Group, developers of state-of-the-art cyber products and services. He is a retired Lieutenant Colonel from the British Army and has worked within the challenging, high threat cyber and communications environment for over 30 years. He holds a BSc in computer science, MSc in design of computer systems and an MBA. He is a member of the UKspace trade association and the National Security and Resilience Consortium, and is a chartered engineer.
Roy Williamson has been helping companies see how their new innovations can disrupt markets for over 20 years.
For the past six years has been successfully helping early stage companies identify and define their strengths, enhance their uniqueness and develop their storylines to engage investors. Roy’s background is in engineering and cleantech and since 2013, he’s been supporting SMEs and entrepreneurs across a broad area of technologies and innovative business models.
Roy is an aeronautical engineer and started his career at Alstom, developing algorithms and models to estimate hardware costs of power generation gas turbines based purely on, often novel, thermodynamic cycles. He has assessed innovation ecosystems of the UK, published by the Organisation for Economic Co-operation and Development. He has also co-authored guides to support technology developers in the UK automotive sector assess technology readiness levels and help those in the biofuels sector to review pathways for second generation biofuels. He’s appraised novel technology solutions for blue-chip clients, developed proof of concepts and carried out due diligence activities to support investor decision making. He is passionate about the UK and knowledge-intensive companies, from software to deeptech.
Roy is Head of Origination at the Department for International Trade with relationships across the department’s teams, government and the UK’s innovation and investment ecosystem.
Professor Mark Arthur Tooley FREng is the immediate Past President of the Institute of Physics and Engineering in Medicine. He was the Head of the Department of Medical Physics and Bioengineering and Director of Research and Development at the Royal United Hospitals, Bath until 2017 when he retired from full-time NHS work. Since then, he has held several part-time roles. He is a specialist scientific advisor for NHS England, a digital clinical advisor for the West of England Academic Health Science network, and a healthcare technology consultant. He is a registered Consultant Clinical Scientist, an honorary professor at the University of Bath, and a visiting professor at the University of the West of England.
Mark completed his BSc in Electrical and Electronic Engineering at the University of Bath in 1979. He was sponsored by Westinghouse Brake and Signal company for the four years of the course. He then did an MSc and PhD in Medical Physics at the University of London. His MSc thesis was developing a EEG frequency analyser for anaesthesia. For his PhD research, Mark invented (with a cardiologist) an original method for rate-independent diagnosis of cardiac rhythm for implantable devices, which was patented. He spent the rest of his career in Medical Physics and Bioengineering departments, both in hospitals and academia, working along medical colleagues. He has worked at St Bartholomew’s hospital in London, Bristol University, United Bristol healthcare NHS Trust, and the Royal United Hospital, Bath. He is a Fellow of the Royal Academy of Engineering, the Royal College of Physicians, the Institute of Engineering and Technology, the Institute of Physics and Engineering in Medicine, and the Institute of Physics. He is a chartered engineer and chartered scientist. Mark is on the peer-review college of EPSRC, has recently been a member of the Engineering and Physical Sciences Research Council Healthcare Technologies Strategic Advisory Team and the Royal Society Fellowship panel.
Mark has been a long-standing member of the Panel for Biomedical Engineering at the Royal Academy of Engineering (now called the healthcare policy topic group). He was recently a member of the biomedical engineering membership panel, the Policy Committee, and the working group for Systems thinking in healthcare. He has mentored on the enterprise scheme.
Mark’s research interests include innovations in medicine, physics applications in anaesthesia, simulation in medicine, physiological measurement, biological signal processing, measuring the depth of anaesthesia, blood pressure measurement and novel patient monitoring solutions.
Dr Liane Smith FREng founded Intetech Ltd in 1991, winning the Queen’s Award for Innovation in 2012 for its software. She sold the business to Wood Group in 2013 and in 2018 she left to form a new consulting engineering business, Larkton Ltd.
Liane is enthusiastic about the capability of digital technologies to transform businesses, bringing efficiencies, cost reduction, production control and increasing safety. In her last role as Senior Vice President Digital Solutions for Wood, she built the new global service line and defined its strategy roadmap and development plan. Her expertise is in various specialist branches of engineering in the industrial and energy sectors and in software product design and commercialisation, data management, data analysis, and analytics.
“I try to fill in gaps in mentees experience and give them confidence in their decisions. Typically we touch on building strong teams, role and task delegation, agile development, growing sales, exporting and strategy."